FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/21/2022
Back to search
Official data from USPTO
BIO DESIGN LAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
12/21/2022
Trademark type
Combined
Nice classes
5
Filing date
07/14/2021
Registration date
08/16/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2022
Last transaction
08/16/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
JACKSON, SHA-KARA ELOUISE
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a circular circuit board with the outline of a seahorse in its center followed by the wording "BIO DESIGN LAB".
Holders and representatives
Holders
BioDesign Lab Co.,Ltd.
Representatives
Jong Park The PL Law Group, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating metabolic disorders; vaccines against flu; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; pharmaceutical agents affecting digestive organs; stem cells for veterinary purposes; antibodies for veterinary purposes; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; allergy medications; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; medicines for the treatment of gastrointestinal diseases; nucleic acid sequences for medical and veterinary purposes; cells for medical purposes; reagents for use in medical genetic testing; diagnostic preparations for medical purposes; human immune globulin; pharmaceutical preparations for the treatment of auto-immune diseases; stem cells for medical purposes; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis; anti-viral agents
Publications
History of USPTO decisions and trademark events.
23 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/29/2022
FIMP
FINAL DISPOSITION PROCESSED
11/29/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/16/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/16/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/16/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/31/2022
PUBO
PUBLISHED FOR OPPOSITION
05/31/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/11/2022
RFNT
REFUSAL PROCESSED BY IB
05/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/21/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/18/2022
RFRR
REFUSAL PROCESSED BY MPU
04/18/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/13/2022
CNRT
NON-FINAL ACTION WRITTEN
04/12/2022
DOCK
ASSIGNED TO EXAMINER
04/04/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
09/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/03/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/02/2021
Continuous trademark protection
Get notified about every new filing that threatens BIO DESIGN LAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.